Contrast Agent-Free 3D Renal Ultrafast Doppler Imaging Reveals Vascular Dysfunction in Acute and Diabetic Kidney Diseases

Adv Sci (Weinh). 2023 Dec;10(36):e2303966. doi: 10.1002/advs.202303966. Epub 2023 Oct 17.

Abstract

To combat the irreversible decline in renal function associated with kidney disease, it is essential to establish non-invasive biomarkers for assessing renal microcirculation. However, the limited resolution and/or vascular sensitivity of existing diagnostic imaging techniques hinders the visualization of complex cortical vessels. Here, a 3D renal ultrafast Doppler (UFD) imaging system that uses a high ultrasound frequency (18 MHz) and ultrahigh frame rate (1 KHz per slice) to scan the entire volume of a rat's kidney in vivo is demonstrated. The system, which can visualize the full 3D renal vascular branching pyramid at a resolution of 167 µm without any contrast agent, is used to chronically and noninvasively monitor kidneys with acute kidney injury (AKI, 3 days) and diabetic kidney disease (DKD, 8 weeks). Multiparametric UFD analyses (e.g., vessel volume occupancy (VVO), fractional moving blood volume (FMBV), vessel number density (VND), and vessel tortuosity (VT)) describe rapid vascular rarefaction from AKI and long-term vascular degeneration from DKD, while the renal pathogeneses are validated by in vitro blood serum testing and stained histopathology. This work demonstrates the potential of 3D renal UFD to offer valuable insights into assessing kidney perfusion levels for future research in diabetes and kidney transplantation.

Keywords: 3D ultrafast doppler; acute kidney injury; diabetic kidney disease; renal vascular imaging.

MeSH terms

  • Acute Kidney Injury* / diagnostic imaging
  • Animals
  • Contrast Media
  • Diabetes Mellitus*
  • Diabetic Nephropathies* / diagnostic imaging
  • Kidney / diagnostic imaging
  • Rats
  • Ultrasonography, Doppler / methods

Substances

  • Contrast Media